Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Jové M[au]:

Lipidomics of human brain aging and Alzheimer's disease pathology. Naudí A et al. Int Rev Neurobiol. (2015)

A plasma metabolomic signature discloses human breast cancer. Jové M et al. Oncotarget. (2017)

<i>TSHB</i> mRNA is linked to cholesterol metabolism in adipose tissue. Moreno-Navarrete JM et al. FASEB J. (2017)

Search results

Items: 1 to 50 of 119

1.

Lipid profile of cerebrospinal fluid in multiple sclerosis patients: a potential tool for diagnosis.

Nogueras L, Gonzalo H, Jové M, Sol J, Gil-Sanchez A, Hervás JV, Valcheva P, Gonzalez-Mingot C, Solana MJ, Peralta S, Pamplona R, Brieva L.

Sci Rep. 2019 Aug 5;9(1):11313. doi: 10.1038/s41598-019-47906-x.

2.

Precision pharmacology: Mass spectrometry imaging and pharmacokinetic drug resistance.

Jove M, Spencer J, Clench M, Loadman PM, Twelves C.

Crit Rev Oncol Hematol. 2019 Sep;141:153-162. doi: 10.1016/j.critrevonc.2019.06.008. Epub 2019 Jul 5. Review.

PMID:
31302407
3.

Cellular Uptake and Efflux of Palbociclib In Vitro in Single Cell and Spheroid Models.

Jove M, Spencer JA, Hubbard ME, Holden EC, O'Dea RD, Brook BS, Phillips RM, Smye SW, Loadman PM, Twelves CJ.

J Pharmacol Exp Ther. 2019 Aug;370(2):242-251. doi: 10.1124/jpet.119.256693. Epub 2019 Jun 12.

PMID:
31189729
4.

A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma.

Servià L, Jové M, Sol J, Pamplona R, Badia M, Montserrat N, Portero-Otin M, Trujillano J.

Scand J Trauma Resusc Emerg Med. 2019 May 22;27(1):56. doi: 10.1186/s13049-019-0631-5.

5.

Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease.

Hernández-Alvarez MI, Sebastián D, Vives S, Ivanova S, Bartoccioni P, Kakimoto P, Plana N, Veiga SR, Hernández V, Vasconcelos N, Peddinti G, Adrover A, Jové M, Pamplona R, Gordaliza-Alaguero I, Calvo E, Cabré N, Castro R, Kuzmanic A, Boutant M, Sala D, Hyotylainen T, Orešič M, Fort J, Errasti-Murugarren E, Rodrígues CMP, Orozco M, Joven J, Cantó C, Palacin M, Fernández-Veledo S, Vendrell J, Zorzano A.

Cell. 2019 May 2;177(4):881-895.e17. doi: 10.1016/j.cell.2019.04.010.

PMID:
31051106
6.

Redox lipidomics to better understand brain aging and function.

Pamplona R, Borras C, Jové M, Pradas I, Ferrer I, Viña J.

Free Radic Biol Med. 2019 Mar 18. pii: S0891-5849(19)30077-2. doi: 10.1016/j.freeradbiomed.2019.03.016. [Epub ahead of print] Review.

PMID:
30898667
7.

[De novo biosynthesis of glycerophospholipids and longevity].

Mota-Martorell N, Pradas I, Jové M, Naudí A, Pamplona R.

Rev Esp Geriatr Gerontol. 2019 Mar - Apr;54(2):88-93. doi: 10.1016/j.regg.2018.05.006. Epub 2018 Jul 4. Spanish.

PMID:
30879491
8.

Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project.

Sánchez E, Betriu À, Yeramian A, Fernández E, Purroy F, Sánchez-de-la-Torre M, Pamplona R, Miquel E, Kerkeni M, Hernández C, Simó R, Lecube A; ILERVAS project; ILERVAS Project:, Hernández M, Rius F, Polanco D, Barbé F, Torres G, Suárez G, Portero-Otin M, Jové M, Colàs-Campàs L, Benabdelhak I, Farràs C, Ortega M, Manuel Valdivielso J, Bermúdez-López M, Martínez-Alonso M.

J Atheroscler Thromb. 2019 Mar 6. doi: 10.5551/jat.47498. [Epub ahead of print]

9.

Exceptional human longevity is associated with a specific plasma phenotype of ether lipids.

Pradas I, Jové M, Huynh K, Puig J, Ingles M, Borras C, Viña J, Meikle PJ, Pamplona R.

Redox Biol. 2019 Feb;21:101127. doi: 10.1016/j.redox.2019.101127. Epub 2019 Jan 29.

10.

Lipids and lipoxidation in human brain aging. Mitochondrial ATP-synthase as a key lipoxidation target.

Jové M, Pradas I, Dominguez-Gonzalez M, Ferrer I, Pamplona R.

Redox Biol. 2018 Dec 19:101082. doi: 10.1016/j.redox.2018.101082. [Epub ahead of print] Review.

11.

Adipose TSHB in Humans and Serum TSH in Hypothyroid Rats Inform About Cellular Senescence.

Moreno-Navarrete JM, Liñares-Pose L, Sabater M, Rial-Pensado E, Comas F, Jové M, Latorre J, Ortega F, Ricart W, Portero-Otin M, López M, Fernández-Real JM.

Cell Physiol Biochem. 2018;51(1):142-153. doi: 10.1159/000495170. Epub 2018 Nov 16.

12.

Lipidomics Reveals a Tissue-Specific Fingerprint.

Pradas I, Huynh K, Cabré R, Ayala V, Meikle PJ, Jové M, Pamplona R.

Front Physiol. 2018 Aug 28;9:1165. doi: 10.3389/fphys.2018.01165. eCollection 2018.

13.

Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging.

Domínguez-González M, Puigpinós M, Jové M, Naudi A, Portero-Otín M, Pamplona R, Ferrer I.

Exp Gerontol. 2018 Oct 1;111:218-228. doi: 10.1016/j.exger.2018.07.023. Epub 2018 Aug 2.

PMID:
30077575
14.

Essential physiological differences characterise short- and long-lived strains of Drosophila melanogaster.

Gubina N, Naudi A, Stefanatos R, Jove M, Scialo F, Fernandez-Ayala DJ, Rantapero T, Yurkevych I, Portero-Otin M, Nykter M, Lushchak O, Navas P, Pamplona R, Sanz A.

J Gerontol A Biol Sci Med Sci. 2018 Jun 26. doi: 10.1093/gerona/gly143. [Epub ahead of print]

PMID:
29945183
15.

Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project.

Sánchez E, Lecube A, Betriu À, Hernández C, López-Cano C, Gutiérrez-Carrasquilla L, Kerkeni M, Yeramian A, Purroy F, Pamplona R, Farràs C, Fernández E, Barbé F, Simó R; ILERVAS project, Hernández M, Rius F, Polanco D, de la Torre MS, Torres G, Godoy P, Portero-Otin M, Jové M, Colàs-Compàs L, Benabdelhak I, Miquel E, Ortega M, Valdivielso JM, Bermúdez M, Martínez-Alonso M.

Diabetes Metab. 2018 Apr 13. pii: S1262-3636(18)30079-X. doi: 10.1016/j.diabet.2018.04.002. [Epub ahead of print] No abstract available.

PMID:
29706471
16.

Successful treatment with brigatinib in a patient with ALK-rearranged lung adenocarcinoma who developed crizotinib-induced interstitial lung disease.

Doménech M, Jové M, Aso S, Marín M, Nadal E.

Lung Cancer. 2018 May;119:99-102. doi: 10.1016/j.lungcan.2018.03.014. Epub 2018 Mar 17.

PMID:
29656760
17.

Lipidomics reveals altered biosynthetic pathways of glycerophospholipids and cell signaling as biomarkers of the polycystic ovary syndrome.

Jové M, Pradas I, Naudí A, Rovira-Llopis S, Bañuls C, Rocha M, Portero-Otin M, Hernández-Mijares A, Victor VM, Pamplona R.

Oncotarget. 2017 Dec 17;9(4):4522-4536. doi: 10.18632/oncotarget.23393. eCollection 2018 Jan 12.

18.

Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients.

Eritja N, Jové M, Fasmer KE, Gatius S, Portero-Otin M, Trovik J, Krakstad C, Sol J, Pamplona R, Haldorsen IS, Matias-Guiu X.

Oncotarget. 2017 Nov 20;8(65):109018-109026. doi: 10.18632/oncotarget.22558. eCollection 2017 Dec 12.

19.

Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Cambray S, Portero-Otin M, Jové M, Torreguitart N, Colàs-Campàs L, Sanz A, Benabdelhak I, Yemisci M, Dalkara T, Dönmez-Demir B, Egea J, Purroy F.

Mol Neurobiol. 2018 Jul;55(7):6193-6200. doi: 10.1007/s12035-017-0827-5. Epub 2017 Dec 21.

PMID:
29270918
20.

An Open-Label Study of Sufentanil Sublingual Tablet 30 Mcg in Patients with Postoperative Pain.

Hutchins JL, Leiman D, Minkowitz HS, Jove M, DiDonato KP, Palmer PP.

Pain Med. 2018 Oct 1;19(10):2058-2068. doi: 10.1093/pm/pnx248. Erratum in: Pain Med. 2017 Nov 20;:.

PMID:
29126259
21.

Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance.

Fourcade S, Morató L, Parameswaran J, Ruiz M, Ruiz-Cortés T, Jové M, Naudí A, Martínez-Redondo P, Dierssen M, Ferrer I, Villarroya F, Pamplona R, Vaquero A, Portero-Otín M, Pujol A.

Aging Cell. 2017 Dec;16(6):1404-1413. doi: 10.1111/acel.12682. Epub 2017 Oct 5.

22.

Lipid Profile in Human Frontal Cortex Is Sustained Throughout Healthy Adult Life Span to Decay at Advanced Ages.

Cabré R, Naudí A, Dominguez-Gonzalez M, Jové M, Ayala V, Mota-Martorell N, Pradas I, Nogueras L, Rué M, Portero-Otín M, Ferrer I, Pamplona R.

J Gerontol A Biol Sci Med Sci. 2018 May 9;73(6):703-710. doi: 10.1093/gerona/glx164.

PMID:
28958038
23.

Differential metabolic profiles associated to movement behaviour of stream-resident brown trout (Salmo trutta).

Oromi N, Jové M, Pascual-Pons M, Royo JL, Rocaspana R, Aparicio E, Pamplona R, Palau A, Sanuy D, Fibla J, Portero-Otin M.

PLoS One. 2017 Jul 27;12(7):e0181697. doi: 10.1371/journal.pone.0181697. eCollection 2017.

24.

TSHB mRNA is linked to cholesterol metabolism in adipose tissue.

Moreno-Navarrete JM, Moreno M, Ortega F, Xifra G, Hong S, Asara JM, Serrano JCE, Jové M, Pissios P, Blüher M, Ricart W, Portero-Otin M, Fernández-Real JM.

FASEB J. 2017 Oct;31(10):4482-4491. doi: 10.1096/fj.201700161R. Epub 2017 Jun 23.

25.

Drug delivery in a tumour cord model: a computational simulation.

Hubbard ME, Jove M, Loadman PM, Phillips RM, Twelves CJ, Smye SW.

R Soc Open Sci. 2017 May 24;4(5):170014. doi: 10.1098/rsos.170014. eCollection 2017 May.

26.

Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system.

Naudí A, Cabré R, Dominguez-Gonzalez M, Ayala V, Jové M, Mota-Martorell N, Piñol-Ripoll G, Gil-Villar MP, Rué M, Portero-Otín M, Ferrer I, Pamplona R.

Biochim Biophys Acta Mol Cell Biol Lipids. 2017 May;1862(5):485-495. doi: 10.1016/j.bbalip.2017.02.001. Epub 2017 Feb 7.

PMID:
28185952
27.

A plasma metabolomic signature discloses human breast cancer.

Jové M, Collado R, Quiles JL, Ramírez-Tortosa MC, Sol J, Ruiz-Sanjuan M, Fernandez M, de la Torre Cabrera C, Ramírez-Tortosa C, Granados-Principal S, Sánchez-Rovira P, Pamplona R.

Oncotarget. 2017 Mar 21;8(12):19522-19533. doi: 10.18632/oncotarget.14521.

28.

Specific Metabolomics Adaptations Define a Differential Regional Vulnerability in the Adult Human Cerebral Cortex.

Cabré R, Jové M, Naudí A, Ayala V, Piñol-Ripoll G, Gil-Villar MP, Dominguez-Gonzalez M, Obis È, Berdun R, Mota-Martorell N, Portero-Otin M, Ferrer I, Pamplona R.

Front Mol Neurosci. 2016 Dec 8;9:138. doi: 10.3389/fnmol.2016.00138. eCollection 2016.

29.

Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature.

Moreno-Navarrete JM, Jové M, Padró T, Boada J, Ortega F, Ricart W, Pamplona R, Badimón L, Portero-Otín M, Fernández-Real JM.

Obesity (Silver Spring). 2017 Feb;25(2):391-400. doi: 10.1002/oby.21711. Epub 2016 Dec 21.

30.

Sixty years old is the breakpoint of human frontal cortex aging.

Cabré R, Naudí A, Dominguez-Gonzalez M, Ayala V, Jové M, Mota-Martorell N, Piñol-Ripoll G, Gil-Villar MP, Rué M, Portero-Otín M, Ferrer I, Pamplona R.

Free Radic Biol Med. 2017 Feb;103:14-22. doi: 10.1016/j.freeradbiomed.2016.12.010. Epub 2016 Dec 13.

PMID:
27979658
31.

Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.

Purroy F, Cambray S, Mauri-Capdevila G, Jové M, Sanahuja J, Farré J, Benabdelhak I, Molina-Seguin J, Colàs-Campàs L, Begue R, Gil MI, Pamplona R, Portero-Otín M.

EBioMedicine. 2016 Dec;14:131-138. doi: 10.1016/j.ebiom.2016.11.010. Epub 2016 Nov 9.

32.

Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism.

Jové M, Gatius S, Yeramian A, Portero-Otin M, Eritja N, Santacana M, Colas E, Ruiz M, Pamplona R, Matias-Guiu X.

Oncotarget. 2016 Aug 9;7(32):52364-52374. doi: 10.18632/oncotarget.10564.

33.

7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome.

Gou-Fàbregas M, Macià A, Anerillas C, Vaquero M, Jové M, Jain S, Ribera J, Encinas M.

Sci Rep. 2016 Jun 23;6:28534. doi: 10.1038/srep28534.

34.

Residual mucin and response after neoadjuvant chemotherapy (NAC) in breast cancer.

Jove M, Verghese E, Sharma N, Lane S.

BMJ Case Rep. 2016 May 6;2016. pii: bcr2016214509. doi: 10.1136/bcr-2016-214509.

35.

Deregulation of IGF-binding proteins -2 and -5 contributes to the development of endocrine resistant breast cancer in vitro.

Hawsawi Y, Humphries MP, Wright A, Berwick A, Shires M, Al-Kharobi H, El-Gendy R, Jove M, Twelves C, Speirs V, Beattie J.

Oncotarget. 2016 May 31;7(22):32129-43. doi: 10.18632/oncotarget.8534.

36.

A Stress-Resistant Lipidomic Signature Confers Extreme Longevity to Humans.

Jové M, Naudí A, Gambini J, Borras C, Cabré R, Portero-Otín M, Viña J, Pamplona R.

J Gerontol A Biol Sci Med Sci. 2017 Jan;72(1):30-37. Epub 2016 Mar 24.

PMID:
27013396
37.

Erratum: Obesity changes the human gut mycobiome.

Mar Rodríguez M, Pérez D, Javier Chaves F, Esteve E, Marin-Garcia P, Xifra G, Vendrell J, Jové M, Pamplona R, Ricart W, Portero-Otin M, Chacón MR, Fernández Real JM.

Sci Rep. 2016 Feb 24;6:21679. doi: 10.1038/srep21679. No abstract available.

38.

Targeted activation of CREB in reactive astrocytes is neuroprotective in focal acute cortical injury.

Pardo L, Schlüter A, Valor LM, Barco A, Giralt M, Golbano A, Hidalgo J, Jia P, Zhao Z, Jové M, Portero-Otin M, Ruiz M, Giménez-Llort L, Masgrau R, Pujol A, Galea E.

Glia. 2016 May;64(5):853-74. doi: 10.1002/glia.22969. Epub 2016 Feb 16.

PMID:
26880229
39.

Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer.

Twelves C, Jove M, Gombos A, Awada A.

Crit Rev Oncol Hematol. 2016 Apr;100:74-87. doi: 10.1016/j.critrevonc.2016.01.021. Epub 2016 Jan 23. Review.

40.

Metabolomics uncovers the role of adipose tissue PDXK in adipogenesis and systemic insulin sensitivity.

Moreno-Navarrete JM, Jove M, Ortega F, Xifra G, Ricart W, Obis È, Pamplona R, Portero-Otin M, Fernández-Real JM.

Diabetologia. 2016 Apr;59(4):822-32. doi: 10.1007/s00125-016-3863-1. Epub 2016 Feb 2.

PMID:
26831303
41.

Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis.

Cacabelos D, Ayala V, Granado-Serrano AB, Jové M, Torres P, Boada J, Cabré R, Ramírez-Núñez O, Gonzalo H, Soler-Cantero A, Serrano JC, Bellmunt MJ, Romero MP, Motilva MJ, Nonaka T, Hasegawa M, Ferrer I, Pamplona R, Portero-Otín M.

Neurobiol Dis. 2016 Apr;88:148-60. doi: 10.1016/j.nbd.2016.01.007. Epub 2016 Jan 12.

PMID:
26805387
42.

Obesity changes the human gut mycobiome.

Mar Rodríguez M, Pérez D, Javier Chaves F, Esteve E, Marin-Garcia P, Xifra G, Vendrell J, Jové M, Pamplona R, Ricart W, Portero-Otin M, Chacón MR, Fernández Real JM.

Sci Rep. 2015 Oct 12;5:14600. doi: 10.1038/srep14600. Erratum in: Sci Rep. 2016;6:21679.

43.

Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy.

Ruiz M, Jové M, Schlüter A, Casasnovas C, Villarroya F, Guilera C, Ortega FJ, Naudí A, Pamplona R, Gimeno R, Fourcade S, Portero-Otín M, Pujol A.

Hum Mol Genet. 2015 Dec 15;24(24):6861-76. doi: 10.1093/hmg/ddv375. Epub 2015 Sep 14.

PMID:
26370417
44.

Lipidomics of human brain aging and Alzheimer's disease pathology.

Naudí A, Cabré R, Jové M, Ayala V, Gonzalo H, Portero-Otín M, Ferrer I, Pamplona R.

Int Rev Neurobiol. 2015;122:133-89. doi: 10.1016/bs.irn.2015.05.008. Epub 2015 Jun 19. Review.

PMID:
26358893
45.

Target of rapamycin activation predicts lifespan in fruit flies.

Scialò F, Sriram A, Naudí A, Ayala V, Jové M, Pamplona R, Sanz A.

Cell Cycle. 2015;14(18):2949-58. doi: 10.1080/15384101.2015.1071745.

46.

Nutridynamics: mechanism(s) of action of bioactive compounds and their effects.

Serrano JC, Jove M, Gonzalo H, Pamplona R, Portero-Otin M.

Int J Food Sci Nutr. 2015 Jul;66 Suppl 1:S22-30. Review.

PMID:
26241008
47.

Sufentanil Sublingual Tablet System for the Management of Postoperative Pain after Knee or Hip Arthroplasty: A Randomized, Placebo-controlled Study.

Jove M, Griffin DW, Minkowitz HS, Ben-David B, Evashenk MA, Palmer PP.

Anesthesiology. 2015 Aug;123(2):434-43. doi: 10.1097/ALN.0000000000000746.

PMID:
26079801
48.

Human Aging Is a Metabolome-related Matter of Gender.

Jové M, Maté I, Naudí A, Mota-Martorell N, Portero-Otín M, De la Fuente M, Pamplona R.

J Gerontol A Biol Sci Med Sci. 2016 May;71(5):578-85. doi: 10.1093/gerona/glv074. Epub 2015 May 26.

PMID:
26019184
49.

Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy.

Morató L, Ruiz M, Boada J, Calingasan NY, Galino J, Guilera C, Jové M, Naudí A, Ferrer I, Pamplona R, Serrano M, Portero-Otín M, Beal MF, Fourcade S, Pujol A.

Cell Death Differ. 2015 Nov;22(11):1742-53. doi: 10.1038/cdd.2015.20. Epub 2015 Mar 27.

50.

Recognizing the place of trials with treatment of physician's choice as the control arm.

Twelves C, Jove M, Cortes J.

J Clin Oncol. 2015 Apr 10;33(11):1300-1. doi: 10.1200/JCO.2014.59.3228. Epub 2015 Mar 2. No abstract available.

PMID:
25732168

Supplemental Content

Support Center